US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

40.34

-0.3850-0.95%

Volume:7K

Turnover:279.29K

Market Cap:1.04B

PE:- -

High:40.76

Open:40.76

Low:40.34

Close:40.72

52wk High:42.87

52wk Low:27.30

Shares:25.75M

Float Shares:25.75M

Volume Ratio:4.93

T/O Rate:0.03%

Dividend:0.42

Dividend Rate:1.05%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Merck price target raised to $161 from $127 at Leerink

CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Headlands Research Names Brandon Pallott Chief Commercial Officer

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints

MT Newswires Live

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS

Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/FTXH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":40.335,"timestamp":1789480208080,"preClose":40.72,"halted":0,"volume":6864,"delay":0,"changeRate":-0.00945481335952844,"floatShares":25750002,"shares":25750002,"eps":0,"marketStatus":"Trading","change":-0.385,"latestTime":"09-15 09:51:11 EDT","open":40.76,"high":40.76,"low":40.335,"amount":279290.60016000003,"amplitude":0.010437,"askPrice":40.35,"askSize":700,"bidPrice":40.29,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.72,"sharesOutstanding":850002,"nav":40.41,"aum":1040557580.82,"dividendRate":0.0105,"bidAskSpread":0.001731,"preHourTrading":{"tag":"盘前","latestPrice":40.73,"preClose":40.72,"latestTime":"09:29 EDT","volume":100,"amount":4072.9999999999995,"timestamp":1789478999078,"change":0.01,"changeRate":0.000246,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":40.72,"preClose":40.72,"latestTime":"19:30 EDT","volume":9,"amount":366.48,"timestamp":1789428605981,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":4.927433,"impliedVol":0.059,"impliedVolPercentile":0.5139},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.927433,"shares":25750002,"dividePrice":0.4235,"high":40.76,"amplitude":0.010437,"preClose":40.72,"low":40.335,"week52Low":27.3,"pbRate":"--","week52High":42.87,"institutionHeld":0,"latestPrice":40.335,"committee":-0.166667,"eps":0,"divideRate":0.0105,"volume":6864,"delay":0,"ttmEps":0,"open":40.76,"prevYearClose":32.9401,"prevWeekClose":40.4666,"prevMonthClose":41.3525,"prevQuarterClose":38.1897,"fiveDayClose":40.91,"twentyDayClose":40.21,"sixtyDayClose":35.3766},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FTXH","amount":0.0892,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666450584","title":"Merck price target raised to $161 from $127 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666450584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666450584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948612,"startTime":"0","endTime":"0","summary":"Leerink raised the firm’s price target on Merck (MRK) to $161 from $127 and keeps an Outperform rating on the shares. Published first on TheFly – t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772840.SGD","LU1116320737.USD","LU2491050071.SGD","BK4007","LU1035773651.USD","GDOC","IE00BJT1NW94.SGD","LU0266013472.USD","LU2106854487.HKD","LU1093756325.SGD","SG9999002232.USD","LU0868494708.USD","LU0965509283.SGD","LU2361044949.HKD","SG9999001176.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","BK4550","LU0868494617.USD","LU2023250843.SGD","LU1061106388.HKD","TRUH","IE00BBT3K403.USD","LU0980610538.SGD","LU0320765646.SGD","LU0070302665.USD","LU1571399168.USD","LU1917777945.USD","LU1162221912.USD","LU0477156953.USD","BK4533","BK4559","LU1032466523.USD","LU0985320562.USD","FHLC","LU0265550359.USD","LU0130102774.USD","LU1430594728.SGD","LU2125154778.USD","LU1023059063.AUD","SG9999014575.USD","LU2089984988.USD","LU1066051498.USD","SG9999015358.SGD","LU0203347892.USD","LU2461242641.AUD","LU1941712264.USD","LU0648001328.SGD","LU0208291251.USD","LU1989771016.USD","LU1929549753.HKD","LU1069347547.HKD","LU0130517989.USD","LU1066053197.SGD","LU1585245621.USD","SG9999014542.SGD","LU0942090050.USD","LU1037948541.HKD","IYH","LU1989772923.USD","LU1934455863.HKD","HRTS","LU0211331839.USD","IE00BFTCPJ56.SGD","MRK","SG9999013999.USD","IE00B2B36J28.USD","PPH","LU0432979614.USD","LU2468319806.SGD","LU2023250504.SGD","PAWZ","BK4534","IXJ","LU2125909593.SGD","LU0058720904.USD","LU2361045086.USD","IE00BLSP4452.SGD","LU2357627491.SGD","LU0965509101.SGD","SGXZ57979304.SGD","LU0122379950.USD","LU2361044865.SGD","IE00BN8TJ469.HKD","XLV","LU2112291526.USD","IE00BLSP4239.USD","LU0289739699.SGD","LU2125909247.SGD","JDOC","LU0203345920.USD","IE00BSNM7G36.USD","LU1934455277.USD","BK4588","FTXH","IE0002141913.USD","LU1923622614.USD","LU0238689110.USD","BK4585","LU1941712348.USD","LU1093756168.USD","RXL","IE00B1BXHZ80.USD","LU0234572021.USD","LU1066051811.HKD","SG9999001176.SGD","LU1699723380.USD","SG9999001440.SGD","SG9999015341.SGD","LU0124676726.USD","LU0689626769.HKD","LU0965509010.AUD","IE0009355771.USD","IE000M9KFDE8.USD","LU0823416689.USD","LU0965508806.USD","LU1057294990.SGD","LU0098860793.USD","LU1974910355.USD","LU1066051225.USD","LU1201861249.SGD","LU1291159041.SGD","LU0006306889.USD","LU0265550946.USD","LU1116320901.HKD","VHT","BMED","LU2125154935.USD","LU1934455194.USD","SG9999014567.USD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU2491049909.HKD","LU2491050154.USD","LU0106261372.USD","LU1037948897.HKD","SG9999014559.SGD","BK4516","LU0859254822.USD","LU2433249047.HKD","LU2324357040.USD","LU0861579265.USD","IHE","LU1983299246.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666837885","title":"CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2666837885","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666837885?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:01","pubTimestamp":1788940865,"startTime":"0","endTime":"0","summary":"CD&R appoints Novartis Chair Giovanni Caforio operating advisor to fundsClayton, Dubilier & Rice named Giovanni Caforio an operating advisor to its funds, focusing on healthcare investment sourcing an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9wnhr1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","IHE","IE00BFXG1179.USD","LU0985481810.HKD","LU2242646821.SGD","LU1670710661.SGD","LU1585245621.USD","LU1989771016.USD","LU0321505439.SGD","LU0237698245.USD","LU0096364046.USD","LU1074936037.SGD","LU0306806265.USD","LU1261432733.SGD","LU1670711040.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0061475181.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1236620834.HKD","LU0306807586.USD","LU1323610961.USD","LU1883839398.USD","LU2360032135.SGD","FTXH","LU0225771236.USD","LU1093756168.USD","IE00B2B36J28.USD","BMY","IE00BJJMRZ35.SGD","BK4581","LU2133065610.SGD","BK4534","BK4559","LU1868836757.USD","LU2596442595.SGD","LU0432979614.USD","LU0114720955.EUR","LU1868836591.USD","BK4532","LU0882574055.USD","LU1236620750.USD","LU2242652126.USD","LU0321505868.SGD","LU1291159041.SGD","BK4588","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370615","title":"Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370615?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:10","pubTimestamp":1788901814,"startTime":"0","endTime":"0","summary":"Atai Beckley holds shareholder meeting, quorum met with 65.6% shares representedAtai Beckley held a virtual special shareholder meeting on Sept. 8, 2026 to vote on a merger agreement with Eli Lilly.Sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1JLSHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","LU1548497426.USD","VHT","LU0417517546.SGD","IE00B1BXHZ80.USD","LU0006306889.USD","LU2237443549.SGD","LU0820561909.HKD","LU0203201768.USD","LU0964807845.USD","LU2111349929.HKD","LU2264538146.SGD","SG9999018865.SGD","LU2361045086.USD","LU0256863902.USD","LU0106261372.USD","LU0203202063.USD","LU2357305700.SGD","LU0354030438.USD","LU2023250504.SGD","LU0058720904.USD","ELIL","SG9999018857.SGD","LU1093756168.USD","IE00BJT1NW94.SGD","LU1366192091.USD","RXL","LU2168563687.JPY","LU2023251221.USD","LU0320765992.SGD","LU2491050071.SGD","LU2360106947.USD","LU1551013342.USD","LU2602419157.SGD","IE00BK4W5L77.USD","THNR","IE00BFSS7M15.SGD","CANC","LU0466842654.USD","LU1023059063.AUD","JDOC","SGXZ99366536.SGD","IE00BJJMRY28.SGD","LU0345770993.USD","LU0456855351.SGD","LU2756315664.SGD","TMED","LU1868836757.USD","LU0122379950.USD","LU0097036916.USD","IE0004445015.USD","LU2471134879.HKD","LU2491049909.HKD","LU2896262040.SGD","LU0323591593.USD","LLY","LU1974910355.USD","SGXZ81514606.USD","LLII","IE0001KFT4U8.USD","BK4533","LU2089283258.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1267930730.SGD","LU0820561818.USD","LU1069344957.HKD","LU1868836591.USD","SG9999017495.SGD","HRTS","IHE","LU0823434583.USD","IE00BJJMRX11.SGD","FTXH","LU1712237335.SGD","LU1720051108.HKD","LU1057294990.SGD","OZEM","LU2471134952.CNY","BK4588","LLYZ","LU1868836914.USD","LU2265009873.SGD","LU1035775433.USD","LU2028103732.USD","LU2237443622.USD","LU2756315318.SGD","BK4585","LU0198837287.USD","IE00BKPKM429.USD","LU1629891620.HKD","LU0234572021.USD","LU2108987350.USD","LU2168564149.EUR","LU2237443382.USD","SG9999015945.SGD","LU0158827948.USD","LU1868837136.USD","LU2462157665.USD","LU0882574139.USD","PJP","BK4599","SG9999015986.USD","LU1720051017.SGD","LLYX","LU2237438978.USD","LU2468319806.SGD","LU2456880835.USD","SG9999001176.SGD","LU2471134796.USD","LU1983299246.USD","BK4534","LU0820562030.AUD","LU2023250330.USD","LU1868837300.USD","LU2552382132.HKD","GB00BDT5M118.USD","LU1917777945.USD","PPH","LU0353189763.USD","LU0823416689.USD","IE00B4JS1V06.HKD","LU0114720955.EUR","LU2471134523.USD","ATAI","LU0256863811.USD","IXJ","SG9999014906.USD","LU2168564222.USD","LU0158827781.USD","LU0225283273.USD","LU0133085943.USD","LU2087625088.SGD","LU2361044949.HKD","LU1145028129.USD","BK4581","LU1061106388.HKD","SG9999014880.SGD","LU0786609619.USD","LU0787776722.HKD","IE00BKDWB100.SGD","LU0353189680.USD","SG9999014914.USD","XLV","LU0266013472.USD","LU1691799644.USD","LU0882574055.USD","SGXZ57979304.SGD","LU0061475181.USD","LU0640476718.USD","IE00BWXC8680.SGD","LU0889565916.HKD","LU0289739699.SGD","LU1979441026.SGD","SG9999014898.SGD","LU0672654240.SGD","LU1551013425.SGD","LU2213496289.HKD","LU2750360997.AUD","IE00BJJMRZ35.SGD","LU0109391861.USD","LU2491050154.USD","IE0009355771.USD","IE00B7KXQ091.USD","LU2237443978.SGD","LU1127390331.HKD","LU0471298694.HKD","LU0238689110.USD","LU0943347566.SGD","LU1323610961.USD","LU0354030511.USD","LU2552382215.SGD","TRUH","LU0094547139.USD","IYH","LU0096364046.USD","MEDX","IE00B4R5TH58.HKD","SG9999015952.SGD","BK4539","LU1064131342.USD","LU0385154629.USD","IE00B1XK9C88.USD","SG9999015978.USD","IE00BFTCPJ56.SGD","LU2237443465.HKD","LU0683600562.USD","WDNA","IE00B775H168.HKD","LU0708995401.HKD","LU1804176565.USD","IE0004445239.USD","LU2746668974.SGD","AGNG","LU2106854487.HKD","LU0432979614.USD","LU2324357040.USD","LU2237443895.HKD","LU1623119135.USD","SGXZ31699556.SGD","LU2211815571.USD","LU0109394709.USD","LU0079474960.USD","LU0345770308.USD","FHLC","IE00BN29S564.USD","IE00BFSS8Q28.SGD","BK4516","IE0002141913.USD","LU1280957306.USD","IE00BK4W5M84.HKD","ILDR","LU2417539215.USD","GDOC","LU2361044865.SGD","LU1989771016.USD","LU2750360641.GBP","LU0471298777.SGD","SG9999001176.USD","LU2462591350.SGD","CURE","LU2089984988.USD","ELIS","LU0823434740.USD","MEDI","MHIP","LU2089284900.SGD","LU1814569148.SGD","LU2063271972.USD","LU2552382058.USD","LU2112291526.USD","LU1988902786.USD","IE00BJLML261.HKD","LU2168564065.EUR","BK4007","LU2236285917.USD","LU2271345857.HKD","LU0316494557.USD","IE00B2B36J28.USD","SG9999013999.USD","LU2746668461.USD","LU1093756325.SGD","LU0320765059.SGD","LU2168564495.EUR","SGXZ51526630.SGD","LU0689472784.USD","LU1291159041.SGD","LU0174119429.USD","LU2461242641.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666243377","title":"Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666243377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666243377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:38","pubTimestamp":1788899880,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  slid 1.89% to $92.39 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.The stock's fall snapped a four-day winning streak.Medtronic PLC closed 13.11% below its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Danaher Corp.  fell 1.17% to $205.23, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  eclipsed its 50-day average volume of 7.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU2063271972.USD","LU2125910179.SGD","MDT","LU0170899867.USD","LU2211814178.USD","SG9999013999.USD","LU1989763690.USD","XLV","FHLC","IE000WAW04H5.SGD","BK4581","LU1670627923.USD","GDOC","BMED","LU1280957306.USD","DHR","IE00BJT1NW94.SGD","IHE","LU1023059063.AUD","LU1261432733.SGD","SG9999002232.USD","FTXH","LU0122379950.USD","VHT","IE00BN8TJ469.HKD","JDOC","LU1061106388.HKD","LU2129689431.USD","MEDX","LU0320765059.SGD","IHI","LU0234572021.USD","JNJ","RXL","IXJ","LU1894683348.USD","LU0289960550.SGD","LU1721429741.USD","PJP","LU0162691827.USD","TRUH","TMED","LU1791710400.SGD","LU0496365809.HKD","FMED","BK4534","IE00B3T34201.USD","LU0158827781.USD","ABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377291","title":"Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377291?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:37","pubTimestamp":1788899820,"startTime":"0","endTime":"0","summary":"DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slipped 3.19% to $64.69 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Bristol Myers Squibb Co. closed 5.75% short of its 52-week high of $68.64, which the company reached on August 19th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  remained 1.3 million below its 50-day average volume of 10.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4559","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0237698245.USD","IE00BFXG1179.USD","LU1670711123.USD","LU0306806265.USD","LU1989771016.USD","LU1670710588.SGD","LU1983299246.USD","LU0061475181.USD","BK4581","BK4588","LU0432979614.USD","LU1883839398.USD","LU1093756168.USD","BK4585","LU0225284248.USD","LU1868836591.USD","LU1261432733.SGD","LU0985481810.HKD","LU1868836914.USD","LU1585245621.USD","LU0882574055.USD","LU1718418525.SGD","IHE","IE0002141913.USD","LU2596442595.SGD","LU0321505439.SGD","LU1670710661.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU1074936037.SGD","LU1571399168.USD","LU2242646821.SGD","LU1236620750.USD","LU0096364046.USD","LU1430594728.SGD","LU2360032135.SGD","LU2125154935.USD","BMY","LU1323610961.USD","LU1670711040.USD","LU1868837300.USD","LU2242652126.USD","LU2133065610.SGD","LU1868837136.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1093756325.SGD","LU2125154778.USD","BK4534","LU1868836757.USD","IE00BSNM7G36.USD","LU1032466523.USD","LU1291159041.SGD","LU0225771236.USD","LU0321505868.SGD","BK4532","IE0009355771.USD","LU1236620834.HKD","LU0267386448.USD","LU0306807586.USD","LU0456855351.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666104377","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666104377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666104377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:33","pubTimestamp":1788899580,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.24% to $148.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 5.39% short of its 52-week high of $156.92, which the company reached on August 25th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Eli Lilly & Co.  fell 2.21% to $1,123.91.Trading volume  eclipsed its 50-day average volume of 9.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","FHLC","LU1116320737.USD","BK4516","LU2433249047.HKD","XLV","LU0265550946.USD","LU1989772840.SGD","LU0130517989.USD","LU2125909247.SGD","IE00B1BXHZ80.USD","LU0985320562.USD","IXJ","BK4533","GDOC","BK4559","LU0942090050.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1035773651.USD","JDOC","LU0106261372.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0124676726.USD","LU1093756168.USD","LU2491050071.SGD","SG9999013999.USD","LU1201861249.SGD","LU0965509101.SGD","IE000M9KFDE8.USD","LU0203345920.USD","RXL","LU1162221912.USD","LU1066051225.USD","LU0289739699.SGD","BK4585","LU2361044865.SGD","VHT","LU2023250504.SGD","LU0208291251.USD","LU2468319806.SGD","LU2491050154.USD","BK4588","LU0432979614.USD","LU0122379950.USD","LU0266013472.USD","LU0320765646.SGD","LU0868494617.USD","IE00BLSP4452.SGD","LU1934455863.HKD","LU1989772923.USD","MRK","LU0006306889.USD","SG9999014575.USD","LU2491049909.HKD","LU1934455194.USD","SG9999014542.SGD","SG9999002224.SGD","LU1116320901.HKD","SG9999014567.USD","LU2125909593.SGD","LU2461242641.AUD","LU1941712264.USD","LU1585245621.USD","LU1571399168.USD","IE00BBT3K403.USD","BK4534","SG9999001440.SGD","SG9999002232.USD","LU1032466523.USD","LU2361045086.USD","IE00BSNM7G36.USD","LU1061106388.HKD","LU1989771016.USD","BK4550","LU1023059063.AUD","LU1917777945.USD","LU1291159041.SGD","SG9999015358.SGD","LU1066051811.HKD","LU0980610538.SGD","LU0868494708.USD","FTXH","IE0002141913.USD","LU0070302665.USD","IE00BN8TJ469.HKD","LU1934455277.USD","LU0320765489.SGD","LU0965508806.USD","BK4007","LU0234572021.USD","LU2112291526.USD","LU0098860793.USD","LU1941712348.USD","IHE","LU2125154778.USD","LU1430594728.SGD","LU2106854487.HKD","IYH","LU1923622614.USD","SG9999001176.SGD","LU1066051498.USD","LU0265550359.USD","LU0058720904.USD","LU2361044949.HKD","LU1983299246.USD","HRTS","LU1069347547.HKD","SG9999014559.SGD","IE0009355771.USD","LU2089984988.USD","PAWZ","LU0203347892.USD","IE00BLSP4239.USD","LU1037948897.HKD","SGXZ57979304.SGD","LU0477156953.USD","LU0859254822.USD","LU0861579265.USD","LU2023250843.SGD","LU0648001328.SGD","LU2125154935.USD","LU0689626769.HKD","LU0130102774.USD","BMED","LU0823416689.USD","IE00BJT1NW94.SGD","LU0238689110.USD","LU1929549753.HKD","TRUH","IE00B4R5TH58.HKD","LU2357627491.SGD","LU0965509283.SGD","SG9999015341.SGD","IE00B2B36J28.USD","LU2360032135.SGD","LU1093756325.SGD","LU1974910355.USD","LU0965509010.AUD","LU1699723380.USD","LU1066053197.SGD","PPH","LU1057294990.SGD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666031372","title":"Protagonist Therapeutics Launches USD 300 Million Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics launches USD 300 million share buyback programProtagonist Therapeutics launched a share repurchase program for up to USD 300 million of outstanding common stock.Funding planne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc74SRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","SGXZ80539844.SGD","IE0009355771.USD","PTGX","BK4007","LU0058720904.USD","JNJ","LU1057294990.SGD","IE0002141913.USD","TRUH","LU0689472784.USD","GDOC","LU1506573853.SGD","PJP","IYH","IE00B4R5TH58.HKD","LU2468319806.SGD","IE00B42XCP33.USD","LU0820562030.AUD","IE00BGHQF631.EUR","IE00BFXG1179.USD","LU2487616109.SGD","MEDX","LU1267930813.SGD","LU1718418525.SGD","LU2430703095.HKD","SG9999001440.SGD","LU1032955483.USD","LU0683600562.USD","IE00B19Z3B42.SGD","JDOC","FHLC","LU1244550221.USD","LU1551013342.USD","BK4504","LU1778281490.HKD","IE00BDGV0183.EUR","LU2750360641.GBP","VHT","LU2602419157.SGD","BK4588","BMED","IHE","XLV","LU1066051225.USD","RXL","BK4533","SG9999001176.SGD","LU1145028129.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","FHLC","IDNA","GDOC","AZNH","MEDX","SYNB","SURI","MNTL","TBXU","IEIH","BME","WDNA","GNMX","LLYX","PBE","HRTS","SBIO","NVIB","FBT","LFSC","PJP","MEDI","FTXH","MDTX","APXH","GNOM","IBRN","GSKH","BBP","XPH","PTH","RSPH","CURE","FXH","JDOC","JHMH","IBBQ","PINK","PSIL","IBBJ","IBB","MRNY","PBPH","BBH","HYLG","PSCH","BIB","CANC","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666631372","title":"Headlands Research Names Brandon Pallott Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666631372","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666631372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:17","pubTimestamp":1788895060,"startTime":"0","endTime":"0","summary":"Headlands Research names Brandon Pallott chief commercial officerHeadlands Research appointed Brandon Pallott as chief commercial officer to lead business development and commercial strategy, reportin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL75psbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IXJ","RXL","PJP","LU2089283258.USD","LU1162221912.USD","BK4585","GLAM","LU2089284900.SGD","LU2347655156.SGD","SG9999015978.USD","LU0456855351.SGD","LU0310799852.SGD","TRUH","LU2129689514.USD","IE00BDGV0183.EUR","LU0124676726.USD","LU0820561818.USD","XLV","LU0868494708.USD","LU1023059063.AUD","MEDX","LU1003077747.HKD","VHT","LU2237443895.HKD","PPH","FTXH","JDOC","LU0320765646.SGD","LU2357627491.SGD","LU2468319806.SGD","IE000WAW04H5.SGD","LU2087621335.USD","SG9999011175.SGD","ABBV","LU1670628061.USD","LU1236620750.USD","LU1496350502.SGD","FHLC","IE0002270589.USD","LU0417517546.SGD","SG9999003800.SGD","LU0868494617.USD","LU2023251221.USD","IYH","LU0203345920.USD","LU0965509101.SGD","LU0211328371.USD","IE000F7OJYX1.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666914372","title":"Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666914372","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666914372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:15","pubTimestamp":1788894935,"startTime":"0","endTime":"0","summary":"• Bristol-Myers Squibb faced profit-taking despite positive Phase 2 trial results for arlocabtagene autoleucel.\n• Investors reacted cautiously due to unspecified regulatory timelines and recent clinical trial enrollment pauses.\n• The company reports $48.19B in annual revenue and maintains solid financial operating metrics.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156735-market-movers-bmy-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU1261432733.SGD","LU1983299246.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1868836591.USD","BK4559","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU0306807586.USD","IHE","BK4534","IE0002141913.USD","LU0267386448.USD","LU0432979614.USD","BK4007","LU0456855351.SGD","LU1868836757.USD","LU1868837136.USD","BK4532","LU2242652126.USD","LU1074936037.SGD","LU0225284248.USD","LU1291159041.SGD","LU1236620750.USD","LU2125154935.USD","LU2360032135.SGD","LU1093756168.USD","BK4585","LU1670710588.SGD","LU2125154778.USD","LU2242646821.SGD","LU1430594728.SGD","LU1868836914.USD","IE00BSNM7G36.USD","LU0096364046.USD","LU0882574055.USD","LU1670711040.USD","IE0009355771.USD","BMY","IE00B2B36J28.USD","LU2596442595.SGD","IE00BFXG1179.USD","LU1670710661.SGD","LU0985481810.HKD","LU0868494617.USD","LU0114720955.EUR","LU1323610961.USD","LU1718418525.SGD","LU0225771236.USD","FTXH","LU0237698245.USD","LU1093756325.SGD","LU0306806265.USD","LU1571399168.USD","BK4588","LU0061475181.USD","BK4581","LU1032466523.USD","LU1236620834.HKD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU1989771016.USD","LU1883839398.USD","LU1670711123.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823434740.USD","HRTS","ELIL","LU0787776722.HKD","LU0097036916.USD","LU2236285917.USD","IE0004445239.USD","CURE","LU0266013472.USD","FHLC","IE00B1XK9C88.USD","LLYX","LU1629891620.HKD","LU2471134879.HKD","LU2461242641.AUD","LU2602419157.SGD","LU0316494557.USD","AGNG","LU2552382215.SGD","SG9999015986.USD","LU2237443382.USD","LU1720051017.SGD","LU0882574139.USD","SG9999015978.USD","LU0210536198.USD","LU1548497426.USD","IE00BJJMRX11.SGD","LU2361044949.HKD","VHT","BK4516","SGXZ31699556.SGD","IE00BJT1NW94.SGD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0683600562.USD","LU2456880835.USD","LU2237443978.SGD","LU0786609619.USD","IE00BKPKM429.USD","LU1366192091.USD","LU2211815571.USD","LU1804176565.USD","IE00BN29S564.USD","LU2108987350.USD","PPH","LU0471298777.SGD","LU0889565916.HKD","LU0354030511.USD","IE00BK4W5L77.USD","LU2746668461.USD","IYH","LU0689472784.USD","LU1127390331.HKD","LU1917777945.USD","LU2237438978.USD","LU2552382058.USD","LU1868836591.USD","LU1691799644.USD","SG9999013999.USD","WDNA","LU2023250330.USD","IE00BFTCPJ56.SGD","LU0345770993.USD","SG9999015945.SGD","LU1814569148.SGD","LU2360106947.USD","LU0061475181.USD","BK4533","ILDR","LU2271345857.HKD","LU1267930730.SGD","LU0672654240.SGD","LU0385154629.USD","LU1093756325.SGD","LU1232071149.USD","LU2750360997.AUD","IXJ","LU0079474960.USD","IE00BJJMRY28.SGD","LU0320765059.SGD","LU1023059063.AUD","LU0114720955.EUR","LU2756315318.SGD","CANC","LU2237443622.USD","IE00BJLML261.HKD","LU2168564065.EUR","LU1868837300.USD","LU0820561818.USD","SG9999001176.SGD","BK4599","LU2552382132.HKD","IHE","LU0708995401.HKD","LU1280957306.USD","LU2756315664.SGD","LU0106261372.USD","LU2361045086.USD","LU2237443549.SGD","LU2265009873.SGD","LU0174119429.USD","LU0466842654.USD","LU0256863902.USD","LU0640476718.USD","LU0417517546.SGD","SGXZ51526630.SGD","LU0353189763.USD","LU1061106388.HKD","LU1145028129.USD","LLYZ","LU2168564222.USD","LU2264538146.SGD","LU0882574055.USD","LU2746668974.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2168564149.EUR","LU2168564495.EUR","LLII","LU2471134796.USD","LU1323610961.USD","LU0323591593.USD","LU1064131342.USD","LU2462591350.SGD","LU0820562030.AUD","LU0456855351.SGD","MEDX","GDOC","LU1868836914.USD","LU1551013425.SGD","LU0198837287.USD","IE00B4JS1V06.HKD","LU0158827781.USD","SGXZ81514606.USD","LU2471134523.USD","LU2089284900.SGD","SG9999018865.SGD","LU0006306889.USD","LU0353189680.USD","LU0354030438.USD","GB00BDT5M118.USD","LU0203202063.USD","LU1868836757.USD","FTXH","LU1057294990.SGD","LU0058720904.USD","LU2361044865.SGD","LU2471134952.CNY","SG9999014914.USD","SG9999017495.SGD","IE00BKDWB100.SGD","LU1983299246.USD","SG9999014898.SGD","SG9999018857.SGD","LU1988902786.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1035775433.USD","LU2417539215.USD","LU2357305700.SGD","LU2087625088.SGD","LU2237443465.HKD","LU2750360641.GBP","LU1623119135.USD","BK4581","BK4588","LU2028103732.USD","BK4007","IE0005OL40V9.USD","LU2468319806.SGD","SGXZ57979304.SGD","RXL","LU0345770308.USD","OZEM","BK4534","IE00B2B36J28.USD","TRUH","LU0238689110.USD","LU2023250504.SGD","LU0471298694.HKD","LU0203201768.USD","LU2023251221.USD","LU2111349929.HKD","LU2462157665.USD","MHIP","LU0256863811.USD","LU1093756168.USD","IE00BFSS7M15.SGD","LU1979441026.SGD","BK4585","LU2063271972.USD","LU2491050154.USD","SG9999014906.USD","LU0133085943.USD","THNR","LU1712237335.SGD","SG9999014880.SGD","LU1069344957.HKD","IE0002141913.USD","ELIS","LU2896262040.SGD","LU0225283273.USD","LU0964807845.USD","LU0820561909.HKD","LU0289739699.SGD","SGXZ99366536.SGD","XLV","IE00BJJMRZ35.SGD","LU2112291526.USD","SG9999015952.SGD","LU2168563687.JPY","LU0320765992.SGD","LU0096364046.USD","LU0094547139.USD","LU1551013342.USD","LU2324357040.USD","LU0943347566.SGD","LU0823434583.USD","LU0109391861.USD","MEDI","SG9999001176.USD","LU1291159041.SGD","IE00BWXC8680.SGD","IE0009355771.USD","LU0234572021.USD","LU0158827948.USD","LU1720051108.HKD","LU2237443895.HKD","LU1989771016.USD","IE00BK4W5M84.HKD","TMED","LU0109394709.USD","LU2089984988.USD","JDOC","LU0432979614.USD","LU2213496289.HKD","LU2491050071.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","PJP","LU0122379950.USD","LLY","LU2491049909.HKD","IE0004445015.USD","LU1868837136.USD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665754593","title":"Dow Drops 438 Points on Losses for Amgen, Salesforce Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665754593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665754593?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:45","pubTimestamp":1788875100,"startTime":"0","endTime":"0","summary":"DJ Dow Drops 438 Points On Losses For Amgen, Salesforce SharesThis article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is declining Tuesday morning with shares of Amgen and Salesforce seeing the biggest declines for the blue-chip average.Shares of Amgen  and Salesforce  are contributing to the index's intraday decline, as the Dow  was most recently trading 438 points, or 0.8%, lower.Amgen's shares have declined $30.47, or 7.0%, while those of Salesforce have fallen $11.09, or 4.3%, combining for a roughly 247-point drag on the Dow.Also contributing significantly to the decline are Johnson & Johnson , IBM , and Microsoft .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","IE000F7OJYX1.SGD","LU2095319765.USD","LU0757359954.USD","LU0211331839.USD","LU1069344957.HKD","LU2471134952.CNY","LU1267930813.SGD","BMED","IE0004086264.USD","LU2097829019.USD","XLI","BK4577","LU2097344357.USD","IE00BJTD4N35.SGD","LU2125909247.SGD","SGXZ51526630.SGD","LU2168564222.USD","LU2357305700.SGD","IE0034235303.USD","LU1236620750.USD","LU2506951958.HKD","LU0724617625.USD","HK0000819398.USD","LU1791710582.SGD","LU0251131958.USD","LU1674673691.USD","LU0820561818.USD","LU1935043536.SGD","IE00BHPRN162.USD","LU1037948541.HKD","IE0000B7K699.USD","LU2089984988.USD","LU0006306889.USD","LU1301847155.USD","IE0034235188.USD","HK0000304797.USD","LU1228905037.USD","LU0210528500.USD","LU2487616109.SGD","LU2420271590.USD","LU1235294995.USD","LU1989773731.SGD","NULC","LU1814569148.SGD","OGIG","LU0965509010.AUD","LU1983299246.USD","IE00BKVL7J92.USD","LU0130518102.USD","LU2461242641.AUD","LU2462157665.USD","LU0289739343.SGD","BK4538","LU2063271972.USD","LU2404859741.USD","IE00BYQQ9H92.USD","LU0187121727.USD","LU0289961442.SGD","LU2168564495.EUR","LU0130103400.USD","LU2041044095.USD","LU2361044865.SGD","CRM","IE00B19Z8W00.USD","LU0757359368.USD","LU0070217475.USD","IE00B3T34201.USD","LU2456880835.USD","CNEQ","LU1043141123.HKD","IE00B1BXHZ80.USD","IE0009G5SDU7.USD","LU0097036916.USD","LU0314104364.USD","LU1582987597.SGD","LU0353189680.USD","LU1069347547.HKD","IE0002270589.USD","LU0061474960.USD","LU1116320737.USD","LU0690374615.EUR","LU1868836591.USD","LU1923622614.USD","IBX","LU0912757837.SGD","LU2092627202.USD","SG9999002232.USD","LU0128525929.USD","LU0174119429.USD","BK4535","CMAG","IE00BQXX3F31.USD","LU1670711123.USD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","FDN","LU2077746001.SGD","LU2148611432.USD","XLK","LU1934455194.USD","IE00BLSP4239.USD","LU1235295455.SGD","IBM","LU1188199696.SGD","SG9999015978.USD","SNPE","LU2129689431.USD","IE00BJT1NW94.SGD","LU0094547139.USD","LU1043141396.HKD","BK4567","LU0081259029.USD","LU0640476718.USD","LU1979441026.SGD","LU0198837287.USD","LU1934455863.HKD","LU1046421795.USD","LU2087625088.SGD","LU0823417737.USD","IE00B7KXQ091.USD","LU0251132253.USD","HK0000304805.HKD","LU1670628061.USD","IE00BJLML261.HKD","LU2357627491.SGD","LU0158827781.USD","FHLC","LU0784383803.USD","IE00BDGV0183.EUR","LU0784384876.USD","PBE","LU0353189763.USD","LU0528227936.USD","MEDX","ROM","LU0061474705.USD","BK4607","BK4527","LU1064131342.USD","LU1803068979.SGD","LU1868836757.USD","LU0957791311.USD","IE00B42XCP33.USD","LU2023250330.USD","SG9999001176.SGD","LU2506951875.HKD","LU1868836914.USD","BK4525","LU2720916845.USD","IE00B19Z8X17.USD","LU1323610961.USD","IE0004445015.USD","LU0472753341.HKD","LU2417539215.USD","LU0208291251.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","SG9999004303.SGD","IE00BFXG1179.USD","BK4533","LU0048573561.USD","LU1430594728.SGD","LU1645745479.HKD","LU0096362180.USD","LU2552382132.HKD","LU2168564149.EUR","LU2237438978.USD","IE0034235295.USD","LU1670711040.USD","IE00BMPRXR70.SGD","LU2746668461.USD","LU0143551892.USD","LU1894683348.USD","LU0879622024.SGD","LU2750360641.GBP","LU0342679015.USD","IE00BQXX3D17.EUR","LU2458330169.SGD","BK4503","LU0553294199.USD","IE00B19Z3581.USD","LU1035775433.USD","BK4599","IE000MB6IJN5.SGD","LU1196500208.SGD","LU1244550494.USD","LU0256863902.USD","LU2250418816.HKD","LU0820562030.AUD","LU1951200564.SGD","LU0312595415.SGD","LU0345769128.USD","LU1880398554.USD","LU1153585028.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","XLV","IE0004091025.USD","DGRO","MYMmain","LU1035773651.USD","SGXZ99366536.SGD","EFIV","LU1670710588.SGD","LU2381873111.SGD","LU1988902786.USD","LU1974910355.USD","VUG","LU2491049909.HKD","IE00BN8TJ469.HKD","LU2242652126.USD","SDOW","LU2236285917.USD","LU0109391861.USD","IE00B4JS1V06.HKD","LU0354030438.USD","LU1582986433.USD","SG9999014575.USD","DXD","LU1642822529.SGD","SG9999001077.SGD","IE00B2B36J28.USD","LU2756315664.SGD","LU2764263039.SGD","LU1181866309.USD","LU0069063385.USD","LU0302445910.USD","LU1201861249.SGD","LU0787776722.HKD","IE0002141913.USD","LU0395794307.EUR","SIBM0main","SPTE","LU2092937148.SGD","LU1400636657.SGD","LU0011850046.USD","LU2543165471.USD","BK4598","LU2286300806.USD","BK4516","IHE","IE0001KFT4U8.USD","LU1721428933.USD","DVY","LU1778281490.HKD","LU2242650005.HKD","IE00B3SWFQ91.USD","LU0057025933.USD","MSFW","BK4576","IE00BWXC8680.SGD","LU1496350171.SGD","LU1582986359.USD","LU1935043452.HKD","LU1868837136.USD","GB00BDT5M118.USD","LU0107464264.USD","LU1629891620.HKD","LU1883839398.USD","LU2360032135.SGD","SGXZ23171101.USD","LU0882574139.USD","LU1267930730.SGD","LU0690374961.EUR","LU1429558221.USD","LU2237957902.USD","LU2896262040.SGD","LU0320765059.SGD","LU0795875169.SGD","LU0267386448.USD","LU1718418525.SGD","LU0354030511.USD","MSFL","LU2023250843.SGD","TRUH","BK4579","LU0310800965.SGD","LU0994945656.USD","LU2360108059.USD","LU2999663052.SGD","MSFD","SG9999014914.USD","BK4608","LU2264538146.SGD","LU1914381329.SGD","LU0345770308.USD","LU2361044949.HKD","LU0683600562.USD","LU0965509101.SGD","LU1340139317.AUD","DOG","LU0210536198.USD","LU2279689827.SGD","LU1236620834.HKD","SG9999015358.SGD","LU0203345920.USD","LU0648000940.SGD","LU1823568750.SGD","LU0211327993.USD","LU0444973449.USD","CRMG","LU1548497426.USD","LU1989771016.USD","LU2471134523.USD","BK4602","BK4581","LU1720051108.HKD","LU0203202063.USD","LU1935042215.USD","LU2108987350.USD","LU2462591277.SGD",".DJI","BK4592","LU0432979614.USD","LU0820561909.HKD","BK4585","LU2028103732.USD","LU0347712357.USD","LU0795875086.SGD","LU1989764664.SGD","SG9999002224.SGD","LU1633808545.USD","IE00BDRTCR15.USD","LU1803068623.USD","LU2087621335.USD","SG9999001424.SGD","LU0109394709.USD","LU2083900584.USD","LU0149725797.USD","LU0130517989.USD","LU1221951129.SGD","MSFY","LU2210149790.SGD","LU0175139822.USD","LU0823421333.USD","LU1670710661.SGD","LU1261432733.SGD","SG9999001440.SGD","LU2430703095.HKD","VGT","SG9999000418.SGD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU1023059063.AUD","LU0234570918.USD","LU2237443978.SGD","LU2750360997.AUD","LU0157215616.USD","LU1585245621.USD","LU1868837300.USD","LU0170899867.USD","LU0894485498.HKD","LU2047632596.USD","LU1201861165.SGD","LU0215105999.USD","LU0320765992.SGD","LU0672654240.SGD","FTEC","LU0203347892.USD","LU0719512351.SGD","LU1267930573.SGD","SG9999014567.USD","IE00B3S45H60.SGD","LU0289941410.SGD","LU2129689605.HKD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU2552382215.SGD","MSFO","LU0980610538.SGD","LU1400636574.HKD","LU2065169927.USD","UDOW","BK4097","LU1923623000.USD","GDOC","LU1066051811.HKD","LU0949170772.SGD","IE00BDCRKT87.USD","LU1366192091.USD","LU0494093205.USD","LU2065170008.USD","MSFC","SG9999014542.SGD","LU2413666426.HKD","LU0124676726.USD","SCHD","DIA","SDY","LU1712237335.SGD","LU1202635105.USD","SG9999015986.USD","LU0345768153.USD","LU0320765646.SGD","LU1435385759.SGD","BK4505","HK0000532082.HKD","LU2023251221.USD","LU2125154778.USD","GB00B4LPDJ14.GBP","LU2244417387.USD","LU2413666699.HKD","LU0742534661.SGD","IE00BKDWB100.SGD","BK4559","LU2491050071.SGD","IE000ITXATA3.USD","SG9999014559.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU2491050154.USD","LU2326559502.SGD","LU0072462426.USD","IE00B775SV38.USD","LU0345774631.USD","BK4534","TBXU","LU1059921491.USD","LU0310799852.SGD","BK4612","LU0965508806.USD","LU2054465674.USD","LU1057294990.SGD","LU1983260115.SGD","LU0321505868.SGD","LU1791710400.SGD","TYLG","LU2089284900.SGD","SCHG","LU0080751232.USD","IE00BFSS7M15.SGD","LU2237443382.USD","LU2430703178.SGD","IE00BBT3K403.USD","GB00B4QBRK32.GBP","LU0109392836.USD","LU0545562505.USD","LU1951198990.SGD","BK4587","WQTM","LU0708995401.HKD","LU2242646821.SGD","LU2471134879.HKD","IE0003U64NQ7.SGD","LU0960925559.SGD","LU1989763005.USD","LU1935042991.SGD","LU0029864427.USD","IE00BVYPNW00.USD","IE00BJJMRX11.SGD","LU1564329628.SGD","IE0004445239.USD","LU2242649171.HKD","IE00B775H168.HKD","JNJ","LU0158827948.USD","LU0053666078.USD","LU0127658192.USD","LU1506573853.SGD","LU1366333091.USD","LU2097344431.USD","LU2756315318.SGD","LU1267930490.SGD","LU1316542783.SGD","LU1697837992.HKD","LU0154236417.USD","BK4504","LU1861127337.USD","SG9999018857.SGD","LU2065171311.SGD","LU1032466523.USD","IE00B4YYXB79.USD","LU0138981039.USD","LU1929549753.HKD","MSFT","LU2125154935.USD","LU0266013472.USD","SG9999001176.USD","IE00BQXX3C00.GBP","IE0009355771.USD","LU0444971666.USD","LU0985320562.USD","TTXU","LU0323240290.USD","LU1119994496.HKD","LU0316494557.USD","LU1935043023.USD","LU2211815571.USD","LU2433249047.HKD","RXL","LU0466842654.USD","LU2430703251.USD","IE00BGHQF631.EUR","LU1989772840.SGD","LU1400636491.USD","LU1720051017.SGD","LU2213496289.HKD","LU1582987324.SGD","LU0077335932.USD","LU1564329032.USD","SG9999014880.SGD","BK4550","LU2764263203.CNY","BK4566","IE00B1XK9C88.USD","LU1674673428.USD","LU1232071149.USD","LU1291159041.SGD","LU2463028550.USD","04332","LU0788109477.HKD","LU2275660780.HKD","SGXZ81514606.USD","LU1267930227.SGD","LU0861579265.USD","LU1221951046.USD","LU2347655156.SGD","LU1084165304.USD","LU1334329650.SGD","LU1564329461.SGD","IBBQ","LU2452424414.USD","LU1934455277.USD","LU1244550221.USD","VYMI","LU0345769631.USD","BK4568","SG9999015952.SGD","LU2111349929.HKD","LU2298321311.HKD","LU0314106906.USD","LU2506952097.USD","LU1061106388.HKD","LU0708994859.HKD","LU0871640123.AUD","IE00BFXG0V08.USD","LU0162691827.USD","LU2458330243.SGD","LU2237443549.SGD","SGXZ57979304.SGD","LU0345774391.USD","LU1935042488.USD","HK0000914660.USD","LU0098860793.USD","LU0784385170.HKD","LU1852331112.SGD","LU2271345857.HKD","LU0476273544.USD","LU2112291526.USD","LU0052756011.USD","BK4543","LU0689472784.USD","LU3102509885.SGD","MSFX","LU0943347566.SGD","LU0784385840.USD","SG9999013999.USD","IE000KEQY171.SGD","LU2361045086.USD","LU0792757196.USD","BK4561","LU1145028129.USD","LU2347655073.USD","SGXZ31699556.SGD","SMSFTmain","LU0308772762.SGD","LU0320765489.SGD","IYH","GAMR","LU0323239441.USD","LU0894486033.HKD","LU1066051498.USD","LU0070302665.USD","LU2506952170.USD","LU0868494617.USD","SG9999014906.USD","DJX","LU0072461881.USD","LU0889565916.HKD","LU0289739699.SGD","LU1551013425.SGD","IE00BZ1G4Q59.USD","IE00B5TLWC47.USD","LU1691799644.USD","LU0289960550.SGD","LU2092937221.SGD","HK0000914686.HKD","LU2100268510.USD","SG9999017495.SGD","LU1670627923.USD","IE00BK4W5M84.HKD","VYM","YMAX","LU0211328371.USD","LU0130102774.USD","LU2505996681.GBP","IE000M9KFDE8.USD","LU2237443465.HKD","IE00BJJMRY28.SGD","LU0964807845.USD","FTXH","LU2746668974.SGD","LU2471134796.USD","LU1162221912.USD","LU1127390331.HKD","SG9999015945.SGD","MSFU","MGK","LU0133085943.USD","LU0949170426.SGD","LU0957808578.USD","LU1074936037.SGD","LU1989772923.USD","LU0477156797.USD","LU0390134368.USD","LU2592432038.USD","LU0058720904.USD","LU2125909593.SGD","LU0950375773.USD","IXN","LU2860962120.EUR","LU0345770993.USD","LU1732799900.SGD","LU1839511570.USD","LU0106261372.USD","LU2133065610.SGD","LU0882574055.USD","LU2023250504.SGD","LU2168564065.EUR","LU1989764748.USD","LU0477156953.USD","IE00BLSP4452.SGD","FDVV","LU2106854487.HKD","LU0096364046.USD","LU2265009873.SGD","IE0005OL40V9.USD","LU1917777945.USD","LU2764262908.HKD","IE00BN29S564.USD","LU0276348264.USD","LU0417517546.SGD","LU1670756490.USD","IE00BVYPNV92.GBP","LU1564329115.USD","LU0056508442.USD","LU0689626769.HKD","DJIA","DGRW","JDOC","LU0889565833.HKD","LU1880398471.USD","LU2637965513.SGD","LU0545039389.USD","LU0079474960.USD","LU1121112475.USD","LU1003077747.HKD","LU2237443895.HKD","LU0823417653.USD","SGXZ80539844.SGD","LU1066051225.USD","AMGN","LU0265550946.USD","IBB","BK4588","LU2552382058.USD","LU1815336760.USD","LU0310800379.SGD","LU0889566641.SGD","SKYY","IE000WAW04H5.SGD","BK4548","LU2247934214.USD","IE00B5949003.HKD","IE00B4R5TH58.HKD","LU0965509283.SGD","LU1116320901.HKD","LU2404859667.USD","PJP","LU0823434740.USD","IE000SO60NU8.SGD","TDIV","LU1496350502.SGD","GRNY","LU0095938881.EUR","IE00BSNM7G36.USD","LU0048584097.USD","LU0456855351.SGD","LU0203201768.USD","LU2210150020.SGD","LU1732800096.USD","LU2102340556.USD","LU1551013342.USD","LU1815333072.USD","TOPT","IE00BYXW3230.USD","BK4134","LU2065171402.SGD","LU1032955483.USD","LU1066053197.SGD","LU0323591593.USD","VHT","SG9999015341.SGD","LU0321505439.SGD","LU0348723411.USD","LU1244550577.SGD","SG9999018865.SGD","LU0251142724.SGD","LU2403377893.USD","LU0210533765.USD","BK4532","LU2089283258.USD","IGV","LU2360106780.USD","LU1894683264.USD","DDM","BK4613","LU0238689110.USD","IE00BMPRXN33.USD","IE00BFSS8Q28.SGD","LU0426417589.USD","IE00BJTD4V19.USD","BK4139","LU1623119135.USD","LU2129689514.USD","LU2505996509.AUD","LU0823434583.USD","IE000W1ABFV2.USD","LU2237957811.SGD","LU0859254822.USD","LU2168563687.JPY","LU2468319806.SGD","LU2191332357.HKD","LU0511384066.AUD","LU0823421416.USD","LU1280957306.USD","LU2362541273.HKD","LU2362541513.USD","LU0661504455.SGD","LU0234572021.USD","LU0256863811.USD","IE00B3PB1722.GBP","LU0345768740.USD","LU0738911758.USD","LU1228905540.USD","LU0225283273.USD","LU0726765562.USD","SG9999014898.SGD","IE000YTNTUN2.SGD","LU0171293334.USD","LU0265550359.USD","LU1804176565.USD","BK4023","BBH","LU2954938101.SGD","LU0082616367.USD","BIB","IE0009356076.USD","BK4528","BK4554","LU0426412945.USD","LU1571399168.USD","BK4575","LU0642271901.SGD","LU0557290698.USD","LU2362540622.SGD","LU2602419157.SGD","IE00B19Z9505.USD","LU0128525689.USD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","SBIO","GSKH","FHLC","IBBQ","BME","MDTX","RSPH","LLYX","CNCR","CURE","PBE","PJP","JDOC","IBBJ","BIB","CANC","LFSC","SYNB","FTXH","JHMH","PTH","IBRN","BBH","GPCR","TBXU","WDNA","PBPH","NVIB","HYLG","PSCH","SURI","PSIL","IBB","MEDI","BBP","FBT","PINK","FXH","MEDX","MNTL","HRTS","XPH","AZNH","GNMX","APXH","LENZ","GDOC","GNOM","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327289","title":"Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327289","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327289?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:43","pubTimestamp":1788867829,"startTime":"0","endTime":"0","summary":"Johnson & Johnson Innovation names Silvia Chen head of JLABS ShanghaiJohnson & Johnson Innovation-JJDC appointed Silvia Chen as site head of JLABS Shanghai.Chen brings more than two decades in healthc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9xctQs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","VHT","LU1674673428.USD","IE00B3T34201.USD","LU0345770993.USD","LU0882574055.USD","LU2471134523.USD","LU2505996509.AUD","IE000SO60NU8.SGD","LU1244550577.SGD","TRUH","LU0820561909.HKD","IE0009355771.USD","LU1718418525.SGD","IE00B19Z3581.USD","LU2129689605.HKD","LU2089984988.USD","IXJ","LU2456880835.USD","LU2505996681.GBP","BK4504","LU1280957306.USD","LU1551013425.SGD","LU0203345920.USD","IE00BZ1G4Q59.USD","PJP","JDOC","FTXH","LU2471134952.CNY","LU1043141396.HKD","LU0210528500.USD","LU0426412945.USD","LU0689626769.HKD","LU1066051498.USD","BMED","LU0640476718.USD","JNJ","LU1066053197.SGD","RXL","GDOC","FHLC","LU0058720904.USD","LU0820562030.AUD","XLV","LU0432979614.USD","LU2750360641.GBP","IYH","LU1496350502.SGD","MEDX","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665473327","title":"Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2665473327","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665473327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:41","pubTimestamp":1788867677,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  said Tuesday that its CAR-T cell therapy arlocabtagene autoleucel met the primary and secondary endpoints of a phase 2 trial to treat adults with quadruple-class exposed relapsed and refractory multiple myeloma.The company said the study's results met its primary endpoint of demonstrating a statistically significant and clinically meaningful overall response rate in heavily pretreated adults with the blood cancer with at least four lines of therapy. It also said the study met key secondary endpoints, including a complete response rate in patients with at least three previous lines of therapy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1236620834.HKD","BMY","LU1291159041.SGD","LU0868494617.USD","LU1430594728.SGD","LU1868836914.USD","LU0985481810.HKD","LU0096364046.USD","BK4588","FTXH","LU0267386448.USD","LU1883839398.USD","LU0237698245.USD","LU2125154935.USD","BK4559","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4581","LU1236620750.USD","BK4585","LU1323610961.USD","LU2242652126.USD","LU0321505439.SGD","IE00B2B36J28.USD","LU1868836757.USD","LU0432979614.USD","LU1032466523.USD","LU1093756325.SGD","LU1718418525.SGD","LU0306806265.USD","BK4007","LU1868837300.USD","LU0882574055.USD","LU1585245621.USD","LU1868836591.USD","LU1571399168.USD","LU1670711040.USD","LU1074936037.SGD","IHE","LU0306807586.USD","LU1261432733.SGD","IE0002141913.USD","LU0225284248.USD","LU1868837136.USD","LU0225771236.USD","LU1670710588.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327821","title":"Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327821","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327821?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865885,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) announced positive Phase 2 results from the registrational QUINTESSENTIAL trial of arlocabtagene autoleucel in adult patients w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU1883839398.USD","IE0009355771.USD","LU1670710661.SGD","LU0267386448.USD","BMY","LU0321505868.SGD","LU1291159041.SGD","LU1236620834.HKD","BK4126","LU1074936037.SGD","LU1430594728.SGD","LU1670711123.USD","LU1983299246.USD","LU0985481810.HKD","BBC","LU0456855351.SGD","LU2360032135.SGD","LU0868494617.USD","LU0432979614.USD","LU2596442595.SGD","LU1261432733.SGD","LU1032466523.USD","LU0114720955.EUR","BK4559","BK4588","LU2242652126.USD","LU0882574055.USD","LU1236620750.USD","LU2125154935.USD","IHE","LU1989771016.USD","FTXH","IE00BSNM7G36.USD","LU1093756168.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","LU1868836914.USD","PSIL","LU0237698245.USD","LU0061475181.USD","BK4534","BK4585","LU0225284248.USD","LU1093756325.SGD","LU2133065610.SGD","LU1718418525.SGD","MYE","LU1670710588.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832218","title":"Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832218?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865386,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb's therapy meets mid-stage trial goalSept 8 (Reuters)-Bristol Myers SquibbBMY.Nsaid on Tuesday its experimental cell therapy met the main goal of a mid-stage trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU2596442595.SGD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU0225284248.USD","LU0061475181.USD","BK4534","LU0985481810.HKD","LU1670710661.SGD","LU1093756168.USD","LU0432979614.USD","BK4588","LU0114720955.EUR","LU1883839398.USD","LU0306807586.USD","LU1236620750.USD","LU1718418525.SGD","LU1093756325.SGD","LU1868836914.USD","LU0237698245.USD","LU1989771016.USD","LU1430594728.SGD","LU1291159041.SGD","IHE","LU1868836591.USD","BK4585","IE0009355771.USD","IE00BSNM7G36.USD","LU1670711123.USD","LU1236620834.HKD","LU2242652126.USD","LU0882574055.USD","IE0002141913.USD","FTXH","LU0306806265.USD","LU2360032135.SGD","LU1670710588.SGD","LU0267386448.USD","LU0868494617.USD","LU1983299246.USD","LU0096364046.USD","BK4559","LU0456855351.SGD","BMY","LU1074936037.SGD","LU1032466523.USD","LU1261432733.SGD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU2125154935.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322873","title":"Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322873?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125154778.USD","BK4588","LU0306806265.USD","BK4581","LU2242646821.SGD","LU2596442595.SGD","LU1989771016.USD","LU0321505868.SGD","LU0096364046.USD","BMY","LU1323610961.USD","IHE","LU2242652126.USD","LU1670711040.USD","LU1868836591.USD","LU0432979614.USD","BK4534","LU1236620834.HKD","LU0321505439.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU0225284248.USD","FTXH","LU1074936037.SGD","LU2125154935.USD","LU1868837300.USD","LU1291159041.SGD","LU1261432733.SGD","LU1236620750.USD","LU1032466523.USD","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","LU1883839398.USD","LU0237698245.USD","LU1430594728.SGD","LU0985481810.HKD","LU0267386448.USD","IE0009355771.USD","LU2133065610.SGD","LU1093756325.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU0868494617.USD","LU1093756168.USD","IE0002141913.USD","LU1670710661.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322827","title":"Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322827?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BSNM7G36.USD","BK4532","LU2360032135.SGD","LU0432979614.USD","LU1670711123.USD","LU1585245621.USD","LU0985481810.HKD","LU0096364046.USD","BK4559","FTXH","LU0456855351.SGD","LU0225284248.USD","BK4581","LU2242646821.SGD","LU1989771016.USD","LU1571399168.USD","IE00BFXG1179.USD","LU0267386448.USD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU2242652126.USD","LU0306807586.USD","LU1236620834.HKD","LU0225771236.USD","LU0237698245.USD","IE0002141913.USD","LU1868837300.USD","BK4588","BK4534","BMY","LU1983299246.USD","LU0321505439.SGD","LU1868836591.USD","LU1868836914.USD","LU1074936037.SGD","LU1670711040.USD","IHE","LU0306806265.USD","BK4585","LU1236620750.USD","LU1323610961.USD","LU0882574055.USD","LU1093756168.USD","IE0009355771.USD","LU1032466523.USD","LU1291159041.SGD","LU2133065610.SGD","LU0061475181.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322824","title":"Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322824?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0114720955.EUR","LU2133065610.SGD","LU0267386448.USD","LU0868494617.USD","LU1983299246.USD","LU1868837300.USD","LU1323610961.USD","LU1074936037.SGD","LU2125154935.USD","LU0321505439.SGD","LU1868836914.USD","LU1670711123.USD","LU1868836757.USD","LU1430594728.SGD","IHE","LU0432979614.USD","BMY","LU0456855351.SGD","LU0306806265.USD","IE0009355771.USD","LU0882574055.USD","LU2242652126.USD","LU1718418525.SGD","IE00BJJMRZ35.SGD","LU1670710588.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1291159041.SGD","LU1868836591.USD","LU0096364046.USD","LU0237698245.USD","LU0306807586.USD","BK4007","LU0321505868.SGD","IE00B2B36J28.USD","LU0985481810.HKD","LU0225771236.USD","LU1236620834.HKD","LU1093756168.USD","LU0061475181.USD","LU2125154778.USD","LU1236620750.USD","LU1670711040.USD","FTXH","IE0002141913.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","BK4532","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":204,"code":"91000000","status":"200"}]}}